Mexico
· Delayed Price · Currency is MXN OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of MXN 15.85 billion. The enterprise value is 16.59 billion.
| Market Cap | 15.85B |
| Enterprise Value | 16.59B |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 767.70M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.23% |
| Shares Change (QoQ) | -1.85% |
| Owned by Insiders (%) | 41.90% |
| Owned by Institutions (%) | 25.21% |
| Float | 348.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 12.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.08 |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.83 |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.97 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.04 |
| Interest Coverage | -2.02 |
Financial Efficiency
Return on equity (ROE) is -17.14% and return on invested capital (ROIC) is -16.99%.
| Return on Equity (ROE) | -17.14% |
| Return on Assets (ROA) | -6.62% |
| Return on Invested Capital (ROIC) | -16.99% |
| Return on Capital Employed (ROCE) | -12.27% |
| Weighted Average Cost of Capital (WACC) | 16.60% |
| Revenue Per Employee | 3.65M |
| Profits Per Employee | -1.36M |
| Employee Count | 2,997 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 6.20 |
Taxes
| Income Tax | -282.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.07% in the last 52 weeks. The beta is 1.81, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -28.07% |
| 50-Day Moving Average | 27.29 |
| 200-Day Moving Average | 53.92 |
| Relative Strength Index (RSI) | 30.38 |
| Average Volume (20 Days) | 90 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OPKO Health had revenue of MXN 10.93 billion and -4.06 billion in losses. Loss per share was -5.41.
| Revenue | 10.93B |
| Gross Profit | 3.71B |
| Operating Income | -3.94B |
| Pretax Income | -4.35B |
| Net Income | -4.06B |
| EBITDA | -2.29B |
| EBIT | -3.94B |
| Loss Per Share | -5.41 |
Balance Sheet
The company has 6.64 billion in cash and 7.01 billion in debt, giving a net cash position of -366.58 million.
| Cash & Cash Equivalents | 6.64B |
| Total Debt | 7.01B |
| Net Cash | -366.58M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 22.83B |
| Book Value Per Share | 30.07 |
| Working Capital | 7.84B |
Cash Flow
In the last 12 months, operating cash flow was -3.21 billion and capital expenditures -221.04 million, giving a free cash flow of -3.44 billion.
| Operating Cash Flow | -3.21B |
| Capital Expenditures | -221.04M |
| Free Cash Flow | -3.44B |
| FCF Per Share | n/a |
Margins
Gross margin is 33.93%, with operating and profit margins of -36.08% and -37.19%.
| Gross Margin | 33.93% |
| Operating Margin | -36.08% |
| Pretax Margin | -39.78% |
| Profit Margin | -37.19% |
| EBITDA Margin | -20.99% |
| EBIT Margin | -36.08% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.23% |
| Shareholder Yield | -8.23% |
| Earnings Yield | -25.63% |
| FCF Yield | -21.67% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |